2025-09-09T07:21:40Z
2025-04-10
2025-09-08T14:01:09Z
info:eu-repo/date/embargoEnd/2026-04-10
Little is known about the impact of substance use and psychiatric comorbidities on the management and outcomes of medical inpatients. This study explores the influence of psychiatric comorbidities, and substance use (tobacco, alcohol, and cannabis) on the length of hospital stay (LOS), Health-Related Quality of Life (HRQoL), and functioning in 800 medical inpatients at a high-complexity academic hospital. Multivariate analyses demonstrated that psychiatric comorbidities were associated with reduced HRQoL (beta = -0.050, p-value = 0.017), and impaired functioning (beta = 3.4, p-value
Artículo
Versión aceptada
Inglés
Comorbiditat; Psiquiatria; Abús de substàncies; Comorbidity; Psychiatry; Substance abuse
Elsevier Ltd.
Versió postprint del document publicat a: https://doi.org/10.1016/j.jpsychires.2025.04.006
Journal Of Psychiatric Research, 2025, vol. 186, 322-330
https://doi.org/10.1016/j.jpsychires.2025.04.006
cc-by-nc-nd (c) Elsevier, 2025
http://creativecommons.org/licenses/by-nc-nd/3.0/es/